GO
Loading...

JNJ Q3 Earnings Beats Expectations

Tuesday, 18 Oct 2011 | 7:51 AM ET

Insight on why Johnson & Johnson exceeded his expectations, with Jeff Jonas, GAMCO analyst/portfolio manager, who adds that Johnson & Johnson's pharma business will start to accelerate with new launches and bring leverage to the company's bottom line.